Wall Street analysts expect BioTelemetry Inc (NASDAQ:BEAT) to post sales of $95.88 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for BioTelemetry’s earnings, with the highest sales estimate coming in at $96.00 million and the lowest estimate coming in at $95.77 million. BioTelemetry posted sales of $58.13 million […]
